Ketchum names new healthcare head

Share this article:
Ketchum named Ann Moravick EVP and director, global healthcare and brand advocacy.
Moravick joins the company from Publicis Consultants PR, where she was US CEO.

She is charged with spearheading the growth and expanding the global reach of the agency's healthcare practice by bridging the work of its international offices, and reports to partners Dale Bornstein, director, global practices, and Barri Rafferty, director, New York.

Before Publicis, Moravick spent 18 years at Manning, Selvage & Lee in various roles.

Bornstein said her “integrated approach to healthcare and brand advocacy will serve the evolving needs of our clients and further differentiate Ketchum's healthcare practice from others in the industry. With Ann's diverse experience, both in the US and in Europe, she will prove to be an asset to our healthcare clients as they navigate the global markets.”

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.